News

Groundbreaking new treatment for aggressive breast cancer has 100% survival rate
Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if ...
Yahoo Finance4mon
Ambry Genetics Data Supports Functional Study of BRCA2, Helping Improve Variant Classification for Hereditary BRCA2-Linked Cancers
as well as Ambry Genetics, to understand and evaluate BRCA2 variants for their functional contributions to cancer pathogenesis. The results of this study were integrated into a ClinGen/ACMG/AMP ...
Science Daily4mon
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations ... as the ClinVar BRCA1/2 expert panel and testing laboratories ...
precisionmedicineonline6mon
BRCA1/2 Mutations Aren't Equal: Researchers Push for Reduced Penetrance Pathogenic Variant Category
Monteiro and Pal's team is working closely with Myriad, Ambry, and other genetic testing labs to find ways to harmonize how RPPVs in BRCA1/2 are reported in genetic testing results. They hope to ...
precisionmedicineonline6mon
Ambry Updates Hereditary Cancer Risk Panels With Eye Toward Gene-Disease Validity, Guidelines
associate director and medical science liaison at Ambry Genetics. "We had only traditionally been testing cancer patients for two genes," BRCA1 and BRCA2. With improvements in sequencing capabilities, ...
Eagle-Tribune9mon
Ambry Genetics Announces New Multiomic Exome Test for Improved Rare Disease Detection
Ambry Genetics, a leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., today announced the ExomeReveal™ test, a new multiomic exome sequencing test designed to improve rare ...
Morningstar9mon
Myriad Genetics Boosts Market Position with Improved Payer Dynamics and Higher Test Volumes
It had exclusive testing rights with patents on isolated BRCA1 and BRCA2 genes until ... Labcorp and other smaller labs such as Invitae, Ambry Genetics, Exact Sciences, and Foundation Medicine.
PharmiWeb2y
LifeStrands Genomics and Ambry Genetics to Provide Laboratory Testing for Clinical Implementation Pilots in Phase II of Singapore’s National Precision Medicine Programme
SINGAPORE & ALISO VIEJO, Calif.--(BUSINESS WIRE)--LifeStrands Genomics and Ambry Genetics have joined forces to provide clinical genetic testing services in Singapore. Together, they have been chosen ...
al.com2y
Alabama only state where Medicaid won’t cover some breast cancer screening
“Medicaid covers the BRCA 1 & 2 genetic tests for outpatient hospital laboratories ... said she most often uses the labs Ambry Genetics, Invitae and GeneDX. Even if they aren’t covered by ...
Targeted Oncology2y
Study Identifies Genes Predisposing for Breast Cancer Among Women With DCIS
The researchers looked at 11 cancer predisposition genes (ATM, BARD1, BRCA1, BRCA2, BRIP1 ... 9887 women with DCIS who received genetic testing at Ambry Genetics between March 15, 2012, and December ...
Healthline4y
BRCA Gene Testing
BRCA gene testing can help determine if someone has mutations in these genes and is at a higher risk of developing certain cancers. In this article, we’ll discuss what the BRCA gene test is ...
ascopubs.org4y
Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019
Mutations in BRCA1/2 and Other Panel Genes in Patients With ... and the Cancer Registry of Greater California) to germline genetic testing results from four laboratories (Ambry Genetics, Aliso Viejo, ...